Envestnet Asset Management Inc Atri Cure, Inc. Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 56,656 shares of ATRC stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,656

Previous 46,086 22.94%

Holding current value

$1.96 Million

Previous $1.41 Million 29.76%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$30.4 - $42.4 $321,328 - $448,168	10,570 Added 22.94%	56,656 $1.83 Million
Q4 2024 Feb 12, 2025	SELL	$27.02 - $38.2 $56,850 - $80,372	-2,104 Reduced 4.37%	46,086 $1.41 Million
Q3 2024 Nov 06, 2024	SELL	$20.34 - $29.5 $1.41 Million - $2.05 Million	-69,526 Reduced 59.06%	48,190 $1.35 Million
Q2 2024 Aug 08, 2024	SELL	$19.86 - $29.09 $4,468 - $6,545	-225 Reduced 0.19%	117,716 $2.68 Million
Q1 2024 May 13, 2024	BUY	$28.21 - $37.78 $45,897 - $61,468	1,627 Added 1.4%	117,941 $3.59 Million
Q4 2023 Feb 13, 2024	SELL	$32.99 - $43.25 $22,301 - $29,237	-676 Reduced 0.58%	116,314 $4.15 Million
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $2.7 Million - $3.79 Million	65,653 Added 127.89%	116,990 $5.12 Million
Q2 2023 Aug 04, 2023	SELL	$40.44 - $49.6 $96,611 - $118,494	-2,389 Reduced 4.45%	51,337 $2.53 Million
Q1 2023 May 11, 2023	BUY	$35.87 - $47.22 $105,924 - $139,440	2,953 Added 5.82%	53,726 $2.23 Million
Q4 2022 Feb 07, 2023	SELL	$33.48 - $47.45 $326,697 - $463,017	-9,758 Reduced 16.12%	50,773 $2.25 Million
Q3 2022 Nov 10, 2022	SELL	$38.25 - $52.62 $22,797 - $31,361	-596 Reduced 0.98%	60,531 $2.37 Million
Q2 2022 Aug 03, 2022	BUY	$35.1 - $66.01 $113,022 - $212,552	3,220 Added 5.56%	61,127 $2.5 Million
Q1 2022 May 04, 2022	SELL	$57.43 - $71.39 $37,272 - $46,332	-649 Reduced 1.11%	57,907 $3.8 Million
Q4 2021 Feb 04, 2022	BUY	$63.4 - $87.14 $166,742 - $229,178	2,630 Added 4.7%	58,556 $4.07 Million
Q3 2021 Oct 07, 2021	BUY	$69.28 - $84.46 $153,385 - $186,994	2,214 Added 4.12%	55,926 $3.89 Million
Q2 2021 Aug 04, 2021	BUY	$64.13 - $80.18 $330,012 - $412,606	5,146 Added 10.6%	53,712 $4.26 Million
Q1 2021 May 04, 2021	BUY	$53.79 - $66.98 $1.64 Million - $2.04 Million	30,480 Added 168.53%	48,566 $3.18 Million
Q4 2020 Feb 02, 2021	BUY	$34.56 - $57.55 $231,966 - $386,275	6,712 Added 59.01%	18,086 $1.01 Million
Q3 2020 Oct 09, 2020	BUY	$38.36 - $46.91 $49,446 - $60,466	1,289 Added 12.78%	11,374 $454,000
Q2 2020 Jul 08, 2020	BUY	$31.78 - $51.19 $320,501 - $516,251	10,085 New	10,085 $453,000

Others Institutions Holding ATRC

# of Institutions

232

Shares Held

46.4M

Call Options Held

25.8K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.61B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Atri Cure, Inc. Transaction History